Analytical Data
-
Gene name
NANOGP8
- Application
-
Alternative Names
NANOGP8;Homeobox Protein NANOGP8
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q6NSW7
-
Expression Region
1-305aa
-
AA Sequence
MSVDPACPQS LPCFEASDCK ESSPMPVICG PEENYPSLQM SSAEMPHTET VSPLPSSMDL LIQDSPDSST SPKGKQPTSA ENSVAKKEDK VPVKKQKTRT VFSSTQLCVL NDRFQRQKYL SLQQMQELSN ILNLSYKQVK TWFQNQRMKS KRWQKNNWPK NSNGVTQKAS APTYPSLYSS YHQGCLVNPT GNLPMWSNQT WNNSTWSNQT QNIQSWSNHS WNTQTWCTQS WNNQAWNSPF YNCGEESLQS CMHFQPNSPA SDLEAALEAA GEGLNVIQQT TRYFSTPQTM DLFLNYSMNM QPEDV
-
Molecular Weight
35 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
NANOGP8, a member of the NANOG gene family, plays a crucial role in maintaining pluripotency and self-renewal of embryonic stem cells. As a reprogramming factor, NANOGP8 has garnered attention due to its potential applications in regenerative medicine and cell therapy. Research indicates that NANOGP8 may influence developmental processes and contribute to tumorigenesis, highlighting the need for a deeper understanding of its biological functions. The recombinant protein of NANOGP8 is essential for investigating its mechanisms, interactions, and effects on stem cell behavior. By producing and characterizing NANOGP8 recombinant protein, researchers aim to explore its structural properties, functional roles, and implications in cellular reprogramming and differentiation. This knowledge could offer insights into how to manipulate stem cell states for therapeutic purposes, aiding in the development of novel strategies for treating degenerative diseases and injuries. Furthermore, studying NANOGP8 might unravel its potential regulatory pathways that are pivotal in embryonic development and oncogenesis, thus providing a better understanding of stem cell biology and cancer progression. The advancement of NANOGP8 recombinant protein research holds promise for both basic science and therapeutic innovations, making it a significant focus in the realm of molecular biology and regenerative medicine.











